Dual Antiplatelet Therapy Tailored on the Extent of Platelet Inhibition
Status:
Unknown status
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy (reduction of major ischemic events at
6 and 12 months of follow-up) of a tailored clopidogrel therapy in patients with UA/NSTEMI
undergoing PCI with stent implantation and wiht a documented residual platelet reactivity
assessed by a point of care system (VerifyNow P2Y12).